Dispersible macromolecule compositions and methods for their preparation and use
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/14
A61K-009/16
출원번호
US-0403482
(2003-03-31)
발명자
/ 주소
Platz,Robert
Brewer,Thomas
Boardman,Terrence
출원인 / 주소
Nektar Therapeutics
대리인 / 주소
Patterson &
인용정보
피인용 횟수 :
23인용 특허 :
88
초록▼
A process for preparing ultrafine powders of biological macromolecules comprises atomizing liquid solutions of the macromolecules, drying the droplets formed in the atomization step, and collecting the particles which result from drying. By properly controlling each of the atomization, drying, and c
A process for preparing ultrafine powders of biological macromolecules comprises atomizing liquid solutions of the macromolecules, drying the droplets formed in the atomization step, and collecting the particles which result from drying. By properly controlling each of the atomization, drying, and collection steps, ultrafine dry powder compositions having characteristics particularly suitable for pulmonary delivery for therapeutic and other purposes may be prepared.
대표청구항▼
What is claimed is: 1. A method for preparing dispersible dry powders of biological macromolecules, said method comprising: providing an evaporable liquid medium containing a macromolecule selected from the group consisting of proteins, polypetides, oligopeptides, nucleic acids, and polysaccharides
What is claimed is: 1. A method for preparing dispersible dry powders of biological macromolecules, said method comprising: providing an evaporable liquid medium containing a macromolecule selected from the group consisting of proteins, polypetides, oligopeptides, nucleic acids, and polysaccharides, wherein the concentration of total solids in the liquid medium is less than 10% by weight; atomizing the liquid medium consisiting of said marcomolecule to form droplets by flowing the liquid medium and an atomization gas stream at a gas:liquid mass flow ratio above 5 under conditions selected to form droplets having an average size of between 5 μm and 11 μm; and drying the droplets in a single drying step, in a heated gas stream, wherein the heated gas stream has an outlet temperature of at least 70째 C., to produce particles having a rugosity of at least 2.0 as measured by air permeametry, wherein 90% of the mass of the powder comprises particles having a diameter in the range of between about 0.1 microns and about 7 microns, and wherein the particles have a final moisture content of below 5% by weight. 2. A method of claim 1 further comprising collecting said particles. 3. A method as in claim 1 wherein 90% of the mass of the powder comprises particles having a diameter within the range of 0.4 microns-5 microns. 4. A method as in claim 1 further comprising packaging at least some of the particles in a container, wherein the particles have not been size classified prior to packaging. 5. A method as in claim 4 wherein the particles are packaged in a unit dosage container. 6. A method as in claim 1 wherein the macromolecule is selected from the group consisting of calcitonin, reythropoietin, factor IX, granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, growth hormone, insulin, interferon alpha, interferon beta, interferon gamma, interleukin-2, leutenizing hormone releasing hormone (LHRH), somatostatin, vasopressin analog, follicle stimulating hormone (FSH), amylin, ciliaryneurotrophic factor, growth hormone releasing factor (GRE), insulin-like growth factor, insulinotropin, interleukin-1 receptor antagonist, interleukin-3, interleukin-4, interleukin-6, macrophage colony stimulating factor(M-CSF), nerve growth factor, parathyroid hormone, thymosin alpha 1, factor IIb/IIIa inhibitor, alpha-1 antitrypsin, anti-RSV antibody, deoxyribonuclease (DNase), bactericidal/permeability increasing protein (BPI), anti-CMV antibody, interleukin-1 receptor, and interleukin-1 receptor antagonist. 7. A method as in claim 1 wherein the particles comprise a rugosity measured by air permeability in the range from 3 to 6. 8. A method as in claim 1 wherein the liquid medium comprises an excipient. 9. A method as in claim 1 wherein the liquid medium comprises a solution or suspension. 10. A method as in claim 9 wherein the liquid medium comprises an aqueous solution. 11. A method as in claim 1 wherein the liquid medium comprises ethanol. 12. A composition prepared by the method of claim 1. 13. A composition as in claim 12 wherein the macromolecule is insulin. 14. A composition as in claim 12 in a unit dosage form containing 0.5 mg-15 mg of the composition. 15. A composition as in claim 12 comprising an excipient selected from the group consisting of carbohydrates, amino acids, buffers and salts. 16. A composition as in claim 14 wherein the excipient is selected from the group consisting of monosaccharides, disaccharides, polysaccharides, and hydrophobic amino acids. 17. A composition as in claim 15 wherein the excipient is selected from the group consisting of manitol, trehalose, sodium chloride, sodium citrate, leucine, lactose, raffinose, alanine, and glycine. 18. A method as in claim 1 wherein 95% of the mass of the powder comprises particles having a diameter within the range of 0.4 microns-5 microns.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (88)
Ganderton David (Exeter GB2) Kassem Nuha M. (London GB2), Aerosol carriers.
Evans Richard M. (Westwood MA) Farr Stephen J. (Llandaf GB7), Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol.
Wang Yu-chang J. (Los Altos CA) Lee William A. (Los Altos CA) Narog Blair (Palo Alto CA), Composition and method for administration of pharmaceutically active substances.
Andersson Jan A. R. (S. Sandby SEX) Nilsson Nils G. (Lund SEX) Fagerstrm Per-Olof S. (Bjrred SEX) Wendel Thomas M. (Genarp SEX), Device in connection with an inhaler.
Newell Robert E. (Pinner GB2) Rand Paul K. (Nitchin GB2) Fitzsimmons Robert A. (Barnard Castle GB2), Devices for administering medicaments to patients.
Prestrelski Steven J. (1971 W. Middlefield Rd. ; Unit #5 Mountain View CA 94043) Zhang Mei Z. (444 Via Colinas Thousand Oaks CA 91362), Formulation of a reconstituted protein, and method and kit for the production thereof.
Chien Yie W. (North Brunswick NJ) Kong-Jiann Li John (Plainsboro NJ) Liu Jue-Chen (East Brunswick NJ) Shi Wei-Min (Piscataway NJ) Siddiqui Ovais (Piscataway NJ) Sun Ying (King of Prussia PA), Iontotherapeutic device and process and iontotherapeutic unit dose.
Zoltan Bart J. (Old Tappan NJ) Laube Beth L. (Baltimore MD) Adams ; III George K. (Baltimore MD) Bow Clark F. (Newton NJ) Devito Ralph J. (Stanhope NJ) Harrington Walter (Flanders NJ) Hoffman Louis S, Medication delivery system phase two.
Boyes Robert N. (St. Albans AL GB2) Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL) Pledger Kenneth L. (Huntsville AL), Pharmaceutical formulations comprising microcapsules.
Sarin Virender K. (Libertyville IL) Fox Jack L. (Lake Bluff IL) Gupta Shanker L. (Vernon Hills IL) Absolom Darryl R. (Columbus OH), Pulmonary surfactant protein fragments.
Knight Jack V. (Houston TX) Wilson ; Jr. Samuel Z. (Houston TX), Small particle aerosol generator for treatment of respiratory disease including the lungs.
Knight Jack V. (Houston TX) Gilbert Brian E. (Houston TX) Wilson Samuel Z. (Houston TX) Six Howard R. (East Stroudsborg PA) Wyde Philip R. (Houston TX), Small particle aerosol liposome and liposome-drug combinations for medical use.
Dower Steven K. (Redmond WA) March Carl J. (Bainbridge Island WA) Sims John E. (Seattle WA) Urdal David L. (Seattle WA), Soluble human interleukin-1 receptors, compositions and method of use.
Bckstrm Kjell G. E. (Lund SEX) Dahlbck Carl M. O. (Lund SEX) Edman Peter (Bjrred SEX) Johansson Ann C. B. (Lund SEX), Systemic administration of a therapeutic preparation.
Bckstrm Kjell G. E. (Lund SEX) Dahlbck Carl M. O. (Lund SEX) Edman Peter (Bjrred SEX) Johansson Ann C. B. (Lund SEX), Therapeutic preparation for inhalation.
DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.